Arthro Kinetics researches, develops, manufactures, and markets biological implants in the field of regenerative medicine for the treatment of the human musculoskeletal system. The first product on the market - the CaReS® basic technology (Cartilage Regeneration System) - is a patented collagen type I matrix colonized with autologous cartilage cells used for the regeneration of articular cartilage defects.
Based on the experiences with the CaReS® basic technology, Arthro Kinectics developed CaReS®-1S (Cartilage Regeneration System -OneStep). This implant is based on the same type I collagen matrix, but it is primarily cell-free and colonized by cells from the environment. It is a certified medical device and its regenerative potential is comparable to that of cellular implants.
The company's operating business is controlled by Arthro Kinetics Biotechnology GmbH in Krems/Danube, Austria:
Headquarters & Administration
- R & D Department
- Quality Control
- Regulatory & Clinical Affairs
- Management Marketing & Sales